HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.

Abstract
A two-step diagnostic algorithm is recommended to detect Clostridium difficile infections; however, samples are regularly found that are glutamate dehydrogenase (GDH) positive but stool toxin negative. In the present single-centre prospective study we focused on these 'difficult-to-interpret' samples and characterized them by anaerobic culture, toxigenic culture, slpA sequence typing and multiplex PCR (GenoType CDiff). The majority of stool toxin A and B-negative samples have been caused by toxigenic strains including ribotype 027. The multiplex PCR was faster and more sensitive compared with culture and allowed preliminary identification of hypervirulent strains in stool samples on the same day.
AuthorsJ Stahlmann, M Schönberg, M Herrmann, L von Müller
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 20 Issue 9 Pg. O590-2 (Sep 2014) ISSN: 1469-0691 [Electronic] England
PMID24450741 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • Bacterial Proteins
  • Bacterial Toxins
  • Enterotoxins
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile
Topics
  • Bacterial Proteins (analysis, genetics)
  • Bacterial Toxins (analysis, genetics)
  • Clostridioides difficile (classification, genetics, isolation & purification)
  • Clostridium Infections (diagnosis, microbiology)
  • Enterotoxins (analysis, genetics)
  • Feces (microbiology)
  • Humans
  • Multiplex Polymerase Chain Reaction (methods)
  • Prospective Studies
  • Ribotyping
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: